SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 140 filers reported holding SUTRO BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $596,000 | -36.6% | 114,437 | +0.1% | 0.02% | -22.7% |
| Q1 2022 | $940,000 | -50.6% | 114,312 | -10.6% | 0.02% | -45.0% |
| Q4 2021 | $1,904,000 | -23.5% | 127,925 | -2.9% | 0.04% | -28.6% |
| Q3 2021 | $2,490,000 | +1.3% | 131,792 | -0.3% | 0.06% | +5.7% |
| Q2 2021 | $2,457,000 | -23.6% | 132,174 | -6.5% | 0.05% | -18.5% |
| Q1 2021 | $3,216,000 | -1.4% | 141,290 | -6.0% | 0.06% | -12.2% |
| Q4 2020 | $3,263,000 | – | 150,283 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |